View in EDS

Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.

Saved in:

Bibliographic Details
Title:	Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.
Authors:	Golfier C; Department of Radiation Oncology, Institut de Cancérologie de Lorraine - Alexis-Vautrin, Vandoeuvre-Lès-Nancy, France. c.golfier@nancy.unicancer.fr., Visy A; Department of Radiation Oncology, CHU de La Réunion, Saint Pierre, France., Gueiderikh A; Department of Radiation Oncology, Gustave Roussy, Villejuif, France., Marcel J; Department of Radiation Oncology, Institut de Cancérologie de Lorraine - Alexis-Vautrin, Vandoeuvre-Lès-Nancy, France., Escande A; Department of Radiation Oncology, Pont Saint Vaast, Douai, France., Scala-Bertola J; Department of Pharmacology, CHU de Nancy, Vandœuvre-Lès-Nancy, France., Metzger M; Medical Library, Institut de Cancérologie de Lorraine - Alexis-Vautrin, Vandœuvre-Lès-Nancy, France., Lambert A; Department of Medical Oncology, Institut de Cancérologie de Lorraine - Alexis-Vautrin, Vandœuvre-Lès-Nancy, France., Faivre JC; Department of Radiation Oncology, Institut de Cancérologie de Lorraine - Alexis-Vautrin, Vandoeuvre-Lès-Nancy, France.
Source:	Cancer metastasis reviews [Cancer Metastasis Rev] 2025 Nov 14; Vol. 44 (4), pp. 83. Date of Electronic Publication: 2025 Nov 14.
Publication Type:	Journal Article; Systematic Review
Journal Info:	Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1573-7233
DOI:	10.1007/s10555-025-10296-w